131 related articles for article (PubMed ID: 22260772)
1. Efficient synthesis and cell-based silencing activity of siRNAS that contain triazole backbone linkages.
Efthymiou TC; Huynh V; Oentoro J; Peel B; Desaulniers JP
Bioorg Med Chem Lett; 2012 Feb; 22(4):1722-6. PubMed ID: 22260772
[TBL] [Abstract][Full Text] [Related]
2. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and properties of novel L-isonucleoside modified oligonucleotides and siRNAs.
Zhang J; Chen Y; Huang Y; Jin HW; Qiao RP; Xing L; Zhang LR; Yang ZJ; Zhang LH
Org Biomol Chem; 2012 Oct; 10(37):7566-77. PubMed ID: 22895883
[TBL] [Abstract][Full Text] [Related]
4. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
Gong W; Desaulniers JP
Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
[TBL] [Abstract][Full Text] [Related]
5. Cationic siRNAs provide carrier-free gene silencing in animal cells.
Nothisen M; Kotera M; Voirin E; Remy JS; Behr JP
J Am Chem Soc; 2009 Dec; 131(49):17730-1. PubMed ID: 19928854
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus.
Brzezinska J; D'Onofrio J; Buff MC; Hean J; Ely A; Marimani M; Arbuthnot P; Engels JW
Bioorg Med Chem; 2012 Feb; 20(4):1594-606. PubMed ID: 22264759
[TBL] [Abstract][Full Text] [Related]
7. Potential design rules and enzymatic synthesis of siRNAs.
Sioud M; Leirdal M
Methods Mol Biol; 2004; 252():457-69. PubMed ID: 15017071
[TBL] [Abstract][Full Text] [Related]
8. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
Yoo JW; Kim S; Lee DK
Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
[TBL] [Abstract][Full Text] [Related]
9. Study of modification pattern-RNAi activity relationships by using siRNAs modified with 4'-thioribonucleosides.
Hoshika S; Minakawa N; Shionoya A; Imada K; Ogawa N; Matsuda A
Chembiochem; 2007 Nov; 8(17):2133-8. PubMed ID: 17924376
[TBL] [Abstract][Full Text] [Related]
10. Structural Studies and Gene Silencing Activity of siRNAs Containing Cationic Phosphoramidate Linkages.
Vlaho D; Fakhoury JF; Damha MJ
Nucleic Acid Ther; 2018 Feb; 28(1):34-43. PubMed ID: 29195060
[TBL] [Abstract][Full Text] [Related]
11. Studies on aminoisonucleoside modified siRNAs: stability and silencing activity.
Li ZS; Qiao RP; Du Q; Yang ZJ; Zhang LR; Zhang PZ; Liang ZC; Zhang LH
Bioconjug Chem; 2007; 18(4):1017-24. PubMed ID: 17539595
[TBL] [Abstract][Full Text] [Related]
12. Building siRNAs with Cubes: Synthesis and Evaluation of Cubane-Modified siRNAs.
Hammill ML; Salim L; Tsubaki K; Varley AJ; Kitamura M; Okauchi T; Desaulniers JP
Chembiochem; 2021 Oct; 22(20):2981-2985. PubMed ID: 34319643
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and silencing properties of siRNAs possessing lipophilic groups at their 3'-termini.
Ueno Y; Kawada K; Naito T; Shibata A; Yoshikawa K; Kim HS; Wataya Y; Kitade Y
Bioorg Med Chem; 2008 Aug; 16(16):7698-704. PubMed ID: 18644731
[TBL] [Abstract][Full Text] [Related]
14. RNA interference induced by siRNAs modified with 4'-thioribonucleosides in cultured mammalian cells.
Hoshika S; Minakawa N; Kamiya H; Harashima H; Matsuda A
FEBS Lett; 2005 Jun; 579(14):3115-8. PubMed ID: 15919084
[TBL] [Abstract][Full Text] [Related]
15. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
[TBL] [Abstract][Full Text] [Related]
16. Controlling miRNA-like off-target effects of an siRNA with nucleobase modifications.
Suter SR; Ball-Jones A; Mumbleau MM; Valenzuela R; Ibarra-Soza J; Owens H; Fisher AJ; Beal PA
Org Biomol Chem; 2017 Dec; 15(47):10029-10036. PubMed ID: 29164215
[TBL] [Abstract][Full Text] [Related]
17. Conjugation and Evaluation of Small Hydrophobic Molecules to Triazole-Linked siRNAs.
Peel BJ; Hagen G; Krishnamurthy K; Desaulniers JP
ACS Med Chem Lett; 2015 Feb; 6(2):117-22. PubMed ID: 25699137
[TBL] [Abstract][Full Text] [Related]
18. [Silencing of c-myc gene expression by enzymatically and chemically synthesized siRNAs].
Kabilova TO; Vladimirova AV; Repkova MN; Ven'iaminova AG; Chernolovskaia EL; Vlasov VV
Mol Biol (Mosk); 2006; 40(6):1037-46. PubMed ID: 17209432
[TBL] [Abstract][Full Text] [Related]
19. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.
Takahashi Y; Nishikawa M; Kobayashi N; Takakura Y
J Control Release; 2005 Jul; 105(3):332-43. PubMed ID: 15936841
[TBL] [Abstract][Full Text] [Related]
20. Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA.
Iwase R; Toyama T; Nishimori K
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1451-4. PubMed ID: 18066804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
